Your browser doesn't support javascript.
loading
Resection as first-line therapy for large hepatic sclerosing hemangioma: a case report.
Xu, Li; Yang, Xu; Ke, Shan; Ding, Xue-Mei; Wang, Shao-Hong; Gao, Jun; Sun, Wen-Bing.
Afiliação
  • Xu L; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Yang X; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Ke S; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Ding XM; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Wang SH; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Gao J; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
  • Sun WB; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, Beijing 100043, People's Republic of China.
Onco Targets Ther ; 12: 6839-6842, 2019.
Article em En | MEDLINE | ID: mdl-31692527
ABSTRACT
Hepatic sclerosing hemangioma is a rare benign disease that occurs in association with hepatic cavernous hemangioma degeneration and sclerosis. Recent studies have shown that radiofrequency (RF) ablation is an alternative treatment for hepatic cavernous hemangiomas, even for large hemangiomas (≥10 cm). However, RF ablation might not be suitable to treat large sclerosing hemangiomas. We herein report the successful surgical removal of a large hepatic sclerosing hemangioma after RF ablation treatment failure in a 65-year-old man. In conclusion, we suggest that resection should be chosen as a first-line therapy for the disease.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article